000 01359 a2200313 4500
005 20250516005122.0
264 0 _c20110307
008 201103s 0 0 eng d
022 _a1590-3478
024 7 _a10.1007/s10072-010-0438-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPatti, Francesco
245 0 0 _aTreatment options of cognitive impairment in multiple sclerosis.
_h[electronic resource]
260 _bNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
_cNov 2010
300 _aS265-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aCholinesterase Inhibitors
_xtherapeutic use
650 0 4 _aCognition Disorders
_xcomplications
650 0 4 _aFluoxetine
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aInterferon-beta
_xtherapeutic use
650 0 4 _aMemantine
_xtherapeutic use
650 0 4 _aMultiple Sclerosis
_xcomplications
650 0 4 _aNeuropsychological Tests
700 1 _aLeone, Carmela
700 1 _aD'Amico, Emanuele
773 0 _tNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
_gvol. 31
_gno. Suppl 2
_gp. S265-9
856 4 0 _uhttps://doi.org/10.1007/s10072-010-0438-7
_zAvailable from publisher's website
999 _c20256987
_d20256987